Agilent Technologies (A) : Money flow in the Agilent Technologies (A) stock was negative (7.49 million) on Wednesday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $11.19 million, compared to $18.68 million on downticks. The total uptick to downtick ratio was 0.6, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($7.81 million), indicating selling on the strength. Downtick transaction value in block trades amounted to $7.81 million, indicating persistent selling. Agilent Technologies (A) traded $0.03 higher at $47.01 gaining 0.06% over the previous days close.
Also, Major Brokerage house, Cowen & Company maintains its ratings on Agilent Technologies (NYSE:A). In the latest research report, Cowen & Company raises the target price from $47 per share to $49 per share. According to the latest information available, the shares are now rated Outperform by the analysts at the agency. The rating by the firm was issued on May 26, 2016.
Agilent Technologies (NYSE:A): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $46.96 and $46.82 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $47.18. The buying momentum continued till the end and the stock did not give up its gains. It closed at $47.01, notching a gain of 0.06% for the day. The total traded volume was 2,124,914 . The stock had closed at $46.98 on the previous day.
The stock has recorded a 20-day Moving Average of 4.01% and the 50-Day Moving Average is 4.78%. In a related news,The director of Agilent Technologies Inc, Cullen James sold 16,697 shares at $45.78 on May 27, 2016. The Insider selling transaction had a total value worth of $764,389. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.